Détail de la notice
Titre du Document
Physical therapy for patellofemoral pain: A randomized, double-blinded, placebo-controlled trial
CROSSLEY Kay ; BENNELL Kim ; GREEN Sally ; ...
Background: Although physical therapy forms the mainstay of nonoperative management for patellofemoral pain, its efficacy has not been established. Hypothesis: Significantly more pain relief will be achieved from a 6-week regimen of physical therapy than from placebo treatment. Study Design: Multicenter, randomized, double-blinded, placebo-controlled trial. Methods: Seventy-one subjects, 40 years of age or younger with patellofemoral pain of 1 month or longer, were randomly allocated to a physical therapy or placebo group. A standardized treatment program consisted of six treatment sessions, once weekly. Physical therapy included quadriceps muscle retraining, patellofemoral joint mobilization, and patellar taping, and daily home exercises. The placebo treatment consisted of sham ultrasound, light application of a nontherapeutic gel, and placebo taping. Results: Sixty-seven participants completed the trial. The physical therapy group (N = 33) demonstrated significantly greater reduction in the scores for average pain, worst pain, and disability than did the placebo group (N = 34). Conclusions: A six-treatment, 6-week physical therapy regimen is efficacious for alleviation of patellofemoral pain.
American Orthopaedic Society for Sports Medicine
PMID : 12435653 ISSN : 0363-5465 CODEN : AJSMDO
American journal of sports medicine A. 2002, vol. 30, n° 6, pp. 857-865 [9 pages] [bibl. : 54 ref.]
Pour les membres de la communauté du CNRS, ce document est autorisé à la reproduction à titre gratuit.
Pour les membres des communautés hors CNRS, la reproduction de ce document à titre onéreux sera fournie sous réserve d’autorisation du Centre Français d’exploitation du droit de Copie.

Pour bénéficier de nos services (strictement destinés aux membres de la communauté CNRS (Centre National de la Recherche Scientifique), de l'ESR français (Enseignement Supérieur et Recherche), et du secteur public français & étranger) :